×

Hep C drug wars: GILD a buy?

5:15 PM ET Mon, 22 Dec 2014

Gilead plunged 14 percent on news that Express Scripts is making AbbVie's Hepatitis C drug the exclusive option for patients. Brian Skorney, Baird, has a buy rating on Gilead.